semaglutide coming off shortage list fda status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from drug GLP-1 No Longer on FDA's – Ozempic, Wegovy Shortage Is Officially

GLP-1 functions to stimulate the release of insulin (a hormone that lowers blood sugar) while suppressing the release of glucagon (a hormone that raises blood sugar) from the pancreas

The result has been an explosion in demand, with roughly 40 million Americans having tried a GLP-1 for weight loss, according to a 2026 RAND report

Users are essentially guinea pigs, exposing themselves to unforeseen health complications

Keep the vial in its original box or wrap it in foil if your fridge has internal lights that stay on

Research areas include body weight regulation, glycemic control through dual incretin signaling, cardiovascular metabolic effects, and comparative studies with single-receptor agonists

That is 18 to 24 months from now